Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulating apoptosis: current applications and prospects for future drug development.

H P Deigner1, R Kinscherf

  • 1Institute of Pharmaceutical Chemistry and Institute of Anatomy and Cell Biology III, Im Neuenheimer Feld 364 and 307, Heidelberg, 69120, Germany. Hans-Peter.Deigner@urz.uni-heidelberg.de

Current Medicinal Chemistry
|April 2, 1999
PubMed
Summary

Agents that control programmed cell death (apoptosis) show great promise for treating diseases like cancer and AIDS. This review explores therapeutic targets and strategies, including novel drugs and gene therapy, for various conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac fibrosis induced by high-fat diet in ApoE-deficient male mice is exacerbated by genetic deletion of PACAP-PAC1 signaling.

Journal of neuroendocrinology·2025
Same author

Forearm elevation impairs local static handgrip endurance likely through reduction in vascular conductance and perfusion pressure: revisiting Rohmert's curve.

Scientific reports·2025
Same author

PAC1 deficiency reduces chondrogenesis in atherosclerotic lesions of hypercholesterolemic ApoE-deficient mice.

BMC cardiovascular disorders·2023
Same author

Effect of chronic intermittent hypoxia (CIH) on neuromuscular junctions and mitochondria in slow- and fast-twitch skeletal muscles of mice-the role of iNOS.

Skeletal muscle·2022
Same author

Characterization of atherosclerotic plaques in blood vessels with low oxygenated blood and blood pressure (Pulmonary trunk): role of growth differentiation factor-15 (GDF-15).

BMC cardiovascular disorders·2021
Same author

Effect of cholesterol re-supplementation and atorvastatin on plaque composition in the thoracic aorta of New Zealand white rabbits.

BMC cardiovascular disorders·2020

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Apoptosis, or programmed cell death, is a critical cellular process implicated in numerous diseases.
  • Dysregulation of apoptosis is a hallmark of conditions such as cancer, AIDS, neurodegenerative disorders, and ischemic diseases.

Purpose of the Study:

  • To review cellular pathways regulating apoptosis and identify potential therapeutic targets.
  • To discuss current drug development efforts and therapeutic strategies modulating apoptosis for various diseases.
  • To highlight recent advancements and future directions in apoptosis-targeted therapies.

Main Methods:

  • Review of scientific literature on cellular pathways of programmed cell death.
  • Analysis of mechanistic and biochemical aspects of pro- and anti-apoptotic drug development.

Related Experiment Videos

  • Discussion of therapeutic approaches including small molecule agents and gene therapy.

    • Main Results:

    • Identification of key cellular pathways and targets within programmed cell death.
    • Evaluation of novel low molecular weight agents, such as caspase inhibitors.
    • Assessment of gene therapy applications, including p53 and adenovirus vectors for cancer treatment.

    Conclusions:

    • Modulating apoptosis offers significant therapeutic potential for a range of diseases.
    • Both small molecule inhibitors and gene-based therapies are promising strategies.
    • Continued research into apoptosis mechanisms will drive future therapeutic innovations.